Join our mailing list and receive the monthly BioVox newsletter for free!

RELATED ARTICLES
Saving lives through fundamental research: James Allison wins Dr. Paul Janssen Award 2018

Dr. James Allison has dedicated his career to improving our fundamental understanding of how the adaptive immune system works. Much of what you wi…


The Fournier-Majoie Foundation: guiding cancer research to clinical application

At 77 years of age, Bernard Majoie is as active as ever. As founder of the Fournier-Majoie Foundation, he dedicates his time to the battle against…


A perspective of the future - Towards a cure for cancer and much more

‘Within 10 years we will be able to cure cancer’. A bold statement? Paul Stoffels (CSO J&J) doesn’t think so. He is a believer. He is also pers…

POPULAR TAGS

New in Belgium: a state-of-the-art integrated care cancer center

Written by AVG on in the category Insights with the tags , .


The University Hospital Center in Liège is expanding. The new comprehensive cancer center will be ready in 2018. The center focuses on high quality integrated care, and a large part of the building will be dedicated to outpatients in consultation and day-care without overnight hospitalization. The center will offer multidisciplinary care, focused on the overall wellbeing of the patient.

The University Hospital Center (CHU) in Liège is developing a comprehensive Cancer Institute, aiming to become the leading cancer center in Wallonia and one of the major players in Belgium. The Cancer Institute includes all activities and services to diagnose, treat and help cancer patients. One of the key points is the focus on out-patient care, an important corner-stone of the CHU strategy to focus on the needs of the patients. The Integrated Cancer Center (CIO) will open in 2018.

The 7-floor building will allow for 40.000 consultations a year and includes a wellness facility for patients, centralizes all the laboratories that analyze patient samples, and dedicates several floors to cancer care. The facilities for cancer patients will include: radiotherapy, radiology and nuclear medicine, a day care clinic, clinical research and coordination and offices for all personnel, including psychologists and social care. Through the creation of a Clinical Trial Center, the CHU is committed to increase patient participation in clinical trials and further develop academic clinical research. The clinical trial center will facilitate the administrative and legal aspects of the trials, coordinating with the different departments. The cell therapy lab of Professor Yves Beguin will move to the new facilities and a new centralized biobank will be set up, regrouping all of the biobanking activities of the CHU, and building a unique collection for the hospital that will be standardized and connected to the European networks.

The center is aiming to offer the best possible service to the patient, putting patient care first. This will include multidisciplinary consultations offering patients a full evaluation, whenever possible, in just one day.

Facts & Figures

  • 80.000.000 euro investment for the building (over a 10 year period)
  • 40.000.000 euro investment for equipment (over a 10 year period)
  • 7 floors, 23.000 sq m
  • no overnight hospitalization
  • 2.300 new cancers / year
  • 9.000 PET-CT / year
  • 2.600 radiotherapy treatments / year (multisite)
  • 31.000 chemotherapy preparations / year

Read more about: , .

RELATED ARTICLES
Saving lives through fundamental research: James Allison wins Dr. Paul Janssen Award 2018

Dr. James Allison has dedicated his career to improving our fundamental understanding of how the adaptive immune system works. Much of what you wi…


The Fournier-Majoie Foundation: guiding cancer research to clinical application

At 77 years of age, Bernard Majoie is as active as ever. As founder of the Fournier-Majoie Foundation, he dedicates his time to the battle against…


A perspective of the future - Towards a cure for cancer and much more

‘Within 10 years we will be able to cure cancer’. A bold statement? Paul Stoffels (CSO J&J) doesn’t think so. He is a believer. He is also pers…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

UGent Turnstone KU Leuven Flanders.bio Janssen XpandInnovation Itera Life Science GSK Biowin V-Bio Ventures

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.